Business Context and Reporting Period
This Form 8-K is a current report filed by BioSig Technologies, Inc. (not Streamex Corp.) on April 8, 2021. The registrant is a Delaware corporation with principal executive offices in Westport, Connecticut. Its common stock trades on the NASDAQ Capital Market under the symbol BSGM. The report discloses non-financial corporate events occurring on April 8 and April 9, 2021.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding specific corporate events and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document focuses on strategic and promotional developments rather than financial performance shifts.
Guidance, Outlook, and Management Commentary
- Alliance for Artificial Intelligence in Healthcare (AAIH): On April 9, 2021, the Company announced it accepted an invitation to join the AAIH. This is disclosed under Item 7.01 (Regulation FD Disclosure).
- Product Recognition: On April 8, 2021, the Company announced its Pure EP™ System was featured in an interview in the April issue of EP Lab Digest, a leading publication for electrophysiology professionals. This is disclosed under Item 8.01 (Other Events).
- Forward-Looking Statements: The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached to this report.
Investor Verification Checklist
- Verify the correct registrant name is BioSig Technologies, Inc. (BSGM), as the request metadata incorrectly listed "Streamex Corp."
- Review Exhibit 99.1 for the full text of the press release regarding the AAIH membership.
- Review Exhibit 99.2 for the full text of the press release regarding the EP Lab Digest feature.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.